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Abstract Introduction Within the occupational health
setting, somatoform disorders are a frequent cause of sick
leave. Few validated screening questionnaires for these
disorders are available. The aim of this study is to validate
the PHQ-15 in this setting. Methods In a cross-sectional
study of 236 sicklisted employees, we studied the perfor-
mance of the PHQ-15 in comparison with the Mini Inter-
national Neuropsychiatric Interview (MINI) as golden
reference standard. We approached employees who were
sick listed for a period longer than 6 weeks and shorter than
2 years for participation. This study was conducted on one
location of a large occupation health service in the Neth-
erlands, serving companies with more than 500 employees.
All employees who returned the PHQ-15 were invited for
the MINI interview. Speciﬁcity and sensitivity were cal-
culated for optimal cut point and a receiver operating
characteristic (ROC) was constructed. Results A total of
107 participants consented to participate in the MINI
interview. A non-response analysis showed no signiﬁcant
differences between groups. According to the MINI, the
prevalence of somatoform disorders was 21.5%, and the
most frequent found disorder was a pain disorder. The
PHQ-15 had an optimal cut point of 9 (patients scoring 9 or
higher (C9) were most likely to suffer from a somatoform
disorder), with speciﬁcity and sensitivity equal to 61.9 and
56.5%, respectively. ROCs showed an area under the curve
(AUC) of 0.63. Conclusion The PHQ-15 shows moderate
sensitivity but limited efﬁciency with a cut point of 9 and
can be a useful questionnaire in the occupational health
setting.
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Introduction
Medically Unexplained Symptoms (MUS) and somatoform
disorders occur frequently in sicklisted employees at the
workplace [1]. Somatoform disorders as deﬁned as DSM-
IV category are established in this study by MINI inter-
view. Frequently occurring somatoform disorders are pain
disorders, which include pain with physical factors and
pain with psychological factors. In this study, we use the
term MUS for speciﬁc symptoms occurring in the context
of somatoform disorders. In this study, MUS occur in
combination with disfunctioning as they did lead to job
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this is an important prerequisite for classiﬁcation as
somatoform disorder.
Previous studies reported a prevalence of MUS in this
setting ranging from 10 to 16% [1–3] and this often
coincided with mental disorders such as depressive or
anxiety disorders. Also, there are indications that
somatoform disorders are often presented as musculo-
skeletal symptoms in this setting, inhibiting work func-
tioning [2, 4–6]. In order to offer patients a suitable
treatment, recognition is crucial. However, in the occu-
pational health (OH) setting, somatoform disorders are
often not recognized [4]. A proper screening tool might be
useful to improve recognition of somatoform disorders in
the OH setting. The use of a routine screener such as the
15-symptom Patient Health Questionnaire (PHQ-15) could
be very useful for the occupational health physician
(OHP) to identify patients who require a more psycho-
logical approach. If a screener for somatoform disorder
is used in an early phase, this might improve clinical
decision-making and selection of relevant treatment
options, even more so now that recently a multidisciplinary
guideline for evidence-based treatment of somatoform
disorders was published [7].
In this study, the Dutch version of the PHQ-15 was
chosen for validation as a screener in the OH setting. The
PHQ-15 is the somatic symptom severity scale of the
Patient Health Questionnaire (PHQ), which is a short,
self-report version of the Primary Care Evaluation of
Mental Disorders (PRIME-MD) developed by Kroenke
and colleagues [8]. The PHQ-15 consists of a list of 15
somatic symptoms. In a validation study in primary care
in Germany, higher scores on the PHQ-15 were strongly
associated with functional impairment, disability, and
health care use [6]. In the Netherlands, in two studies in
the OH setting in sick listed employees, higher scores on
the PHQ-15 were associated with more disability, longer
sickness absence and higher health-related job loss [3, 4].
In a recent review of studies in primary care, the PHQ-15
was found to be equally effective or superior to other
brief measures for assessing somatic symptoms and
screening for somatoform disorders, with cut points of
5, 10 and 15 representing mild, moderate and severe
symptom levels. However, a validation of the PHQ-15 in
the OH setting was not yet performed [9]. Van Ravesteijn
et al. [9] validated the Dutch version of the PHQ-15 for
the primary care setting. Therefore we expected the PHQ-
15 to be a valid instrument for the OH setting as well.
The aim of this study was therefore to validate the PHQ-
15 in the OH setting by comparing the PHQ-15 with the
MINI International Neuropsychiatric Interview (MINI;
this is a short neuropsychiatric interview [10], see sec-
tion 2.7) as golden standard.
Method
This validation study of the PHQ-15 was performed as part
of a cross-sectional survey to assess the prevalence of
severe MUS and psychiatric comorbidity in a sick-listed
population [3], and to validate several questionnaires
against the MINI-interview. Validation of the PHQ-15 is
reported here. The Medical Ethics Committee approved of
the study.
Participants
A total of 776 employees who were sick listed for a period
longer than 6 weeks and shorter than 2 years were
approached to participate at their visit of their OHP at
a large occupation health services in the Netherlands
(ArboNed), Corporate Accounts, from April 2006 until
December 2007. Patients were recruited from one location
of ArboNed, serving companies with more than 500
employees. Individuals unable to ﬁll out the questionnaires
(due to insufﬁcient mastery of the Dutch language) and
persons with psychotic symptoms or at increased risk for
suicide, were excluded from the study. As procedure, over
a period of 6 weeks 12 OHPs were asked to select a 4-h
consultation session every week on the same day. The
practice assistants in the administrative section of the OH
service were instructed to invite all sick-listed employees,
who had an appointment for this session to participate in
the study. The employees who volunteered to participate
received the research questionnaires (including the PHQ-
15) and an informed consent form 1 week before the actual
consultation, or later if they received the invitation after
that time. The OHPs were not involved themselves in the
selection of the patients. The questionnaires were sent to
the Trimbos Institute. After receipt, a blinded Trimbos
Institute research assistant contacted the employee by
telephone for the MINI interview. To assess the validity of
the PHQ-15, we invited all participants who returned the
PHQ-15 (N = 172) for a MINI interview within 2 weeks
after receiving the PHQ-15. The interviewer was blinded
for the scores of the participants on the questionnaires. This
procedure is described more extensively elsewhere [3].
Assessment
Socio-demographic variables, depression, anxiety, distress,
and MUS were assessed in this study.
Objectives
Primary objective was to validate the PHQ-15 for detecting
somatoform disorders in the OH setting by using the MINI
as golden standard.
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The PHQ-15 is the somatic subscale of the PHQ. It com-
prises almost all physical symptoms in the outpatient set-
ting [11]. The PHQ-15 contains 15 items, 13 of which are
based on a 3-point response scale, with ordered response
categories ‘not bothered at all’ (0 points), ‘bothered a little’
(1 point) and ‘bothered a lot’ (2 points). The remaining 2
items consist of questions about ‘feeling tired or having
little energy’ and ‘trouble sleeping’, which are contained in
the depression module of the PHQ. Scores for these 2
questions can be 0, 1, 2 or 3 points depending on the
patient’s response, which is either ‘not at all’, ‘several
days’, ‘more than half the days’ or ‘nearly every day’.
Before adding these item scores to the sum of the total
score based on the other 13 items in the PHQ-15, responses
to these two questions were re-scored as described by
Kroenke et al. (‘not at all’ with 0 points, ‘several days’ with
1 point and ‘more than half of the days’ or ‘nearly every
day’ with 2 points) [11].
MINI Interview
The MINI interview was used as the golden standard in this
study. Based on the DSM-IV criteria, Sheehan et al. [10]
developed this interview, which is often used in the clinic.
The MINI is used to diagnose and classify somatoform
disorders. A trained, blinded research assistant of the
Trimbos Institute conducted the MINI Interview by tele-
phone. Participants were asked about physical symptoms
within the previous 2 weeks to 6 months [10]. In case of
any doubt whether or not a patient suffered from a medi-
cally explained or unexplained condition or pain symptom,
an OHP (RH) or a psychiatrist (CFC) was to be consulted.
Analysis
Construct Validity
First, the mean PHQ-15 scores were calculated both for
patients who according to the MINI suffered from
somatoform disorders, and for subjects who did not. Also,
demographic characteristics of both groups were recorded.
Signiﬁcance of differences was established by chi-square
tests and t tests. We expected that the PHQ-15 scores
would differ between both groups.
Diagnostic Validity
For clinical diagnosis, a test needs to be sensitive enough to
detect the relevant problem if it is present (and therefore
avoid many false negative results), but speciﬁc enough to
keep the number of false positives as low as possible.
Therefore, to assess the research question on the diagnostic
validity of the PHQ-15, based on the sum score of the
PHQ-15 the sensitivity, the speciﬁcity, and the predictive
values were calculated for cut points ranging from 0 to 30.
In order to discern whether the efﬁciency of the PHQ-15
exceeded randomness (50%), sensitivity, speciﬁcity, pre-
dictive values, and efﬁciency (the total percentage of cor-
rect diagnosis, combining positive and negative diagnosis)
were determined for different cut points. This way, an
optimal cut point could be determined and a receiver
operating characteristic (ROC) was calculated to explore
diagnostic performance. An area under the curve (AUC)
was also calculated. Analysis was performed using SPSS
v15. As not all patients who returned the PHQ-15 subse-
quently consented to the MINI interview, a non-response
analysis was performed.
Results
Flowchart
A ﬂowchart of the study is provided in Fig. 1. 776 sick-
listed employees were approached to ﬁll out the PHQ-15,
and 172 (22.1%) returned the questionnaire. Eventually we
analysed the data of 107 persons for whom we obtained
both a PHQ-15 score and a MINI classiﬁcation; this is
13.7% of the persons who were approached to participate
for informed consent initially. In nine cases (8%) the
psychiatrist (CFC) was consulted regarding uncertainty
about the patient suffering from pain syndrome or from
medically explained pain without psychological factors.
Among these nine cases, ﬁve were considered medically
unexplained and were included as pain disorder; four were
assigned to the ‘no somatoform disorder’-group.
Non-Response Analysis
Of the 172 persons who received PHQ-15 questionnaires,
107 participants subsequently underwent the MINI inter-
view, while 65 did not. PHQ-15 scores, demographic
characteristics, gender, marital status, age and level of
education did not differ signiﬁcantly between responders
and non-responders.
MINI Classiﬁcations
MINI classiﬁcations are shown in Table 1.
In the total sample (N = 107), 84 participants did not
fulﬁll diagnostic criteria and were not classiﬁed with a
somatoform disorder according to the MINI interview (i.e.
the ‘‘no-somatoform disorder group’’), and 23 fulﬁlled
classiﬁcation criteria for somatoform disorders (i.e. the
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21.5%. Amongst the somatoform disorders, pain disorders
were the most prevalent with a total prevalence of 47.8%
(N = 11). The next most frequent somatoform disorder
was chronic fatigue, 21.7% (N = 5), followed by IBS
(N = 2, 8.7%) and undifferentiated somatoform disorder
(N = 3, 13.0%). Conversion (N = 1) and somatoform
disorder (N = 1) were scarce.
Demographic Characteristics
None of the demographic characteristics showed a signif-
icant difference between the somatoform disorder group
and the no-somatoform disorder group. The total sample
existed of 53 male (49.5%) participants. The mean age was
47.9 (SD = 9.8). 13.1% (N = 14) of the participants stated
to be single, 74.8% (N = 80) were living together or were
married and 12.1% (N = 13) said to be divorced or be
widow/widower. A total of 31.8% (N = 34) participants
ﬁnished an education at low level, 38.3% (N = 41) at
middle high level and 29.9% (N = 32) at high level.
Before sick leave, participants on average worked 4.2
(SD = 1.2) days a week, which corresponds to 30.3
(SD = 11.2) hours a week. Almost all participants (98.1%)
stated to be in paid employment. Only 12.1% of the par-
ticipants fulﬁlled an executive function and 64.5% declared
to be wage earner. All employees included in the study
were sicklisted during the study.
Mean Scores on PHQ-15
The mean PHQ-15 score in the total study sample was 8.3
(SD = 4.6; range = 1–22). The difference between the
means in the somatoform disorder group (mean = 10.1,
SD = 5.5, range = 1–22) and the no somatoform disorder
group (7.8; SD = 4.1; range = 1–19) was signiﬁcant
(P = 0.030), conﬁrming the construct validity of the PHQ-
15 (Table 1).
Validation Scores
Table 2 shows the sensitivity, the speciﬁcity, and the pre-
dictive values for both positive and negative test results
(positive predictive value (PPV), negative predictive value
(NPV)) and the efﬁciency. These validation scores were
Fig. 1 Report of the number of participants during the course of our
study
Table 1 Disorder classiﬁcations and PHQ-15 scores
Somatoform disorder according to MINI (N = 23)
MINI classiﬁcation
Pain disorder 8
Pain disorder RSI 1
Undif. cardiac pain 1
Undif. soma. dis. ﬁbromyalgia 1
Undif. chronic fatigue 5
Undifferentiated IBS 2
Undif. somatoform 3
Conversion disorder 1
Somatoform disorder 1
Undif undifferentiated, IBS irritable bowl syndrome, RSI repetitive
strain injury, soma. dis. somatoform disorder
Table 2 Validation scores of the PHQ-15
Frequency Score C 6 Score C 7 Score C 8 Score C 9 Score C 10 Score C 11
N = 74 (79.2%)
(%)
N = 61 (65.3%)
(%)
N = 52 (55.6%)
(%)
N = 45 (48.2%)
(%)
N = 37 (39.6%)
(%)
N = 27 (28.9%)
(%)
Sensitivity 82.6 69.6 60.9 56.5 52.2 39.1
Speciﬁcity 34.5 46.4 54.8 61.9 70.2 78.6
NPV 25.7 26.2 26.9 28.9 32.4 33.3
PPV 87.9 84.8 83.6 83.9 84.3 82.5
Efﬁciency 30.8 43.0 51.4 57.9 65.4 74.8
NPV negative predictive value, PPV positive predictive value
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123calculated for the total score on the PHQ-15 that ranged
from 0 to 30. A range of PHQ-15 scores was considered in
order to establish the optimal cut point.
Sensitivity was the highest (82.6%) at a cut point of 6.
However, at cut point 6 the speciﬁcity of 34.5% was
unacceptably low. Maximum speciﬁcity of 78.6% was
found at cut point of 11, but then sensitivity was 39.1%,
NPV was 33.3% and PPV was 82.5%. Efﬁciency was
74.8%, the highest value for all possible cut points. A cut
point of 9 resulted in sensitivity of 56.5% and speciﬁcity of
61.9%, NPV of 28.9%, and PPV of 83.9%. At cut point 9,
efﬁciency was 57.9%.
ROC Analysis
Figure 2 shows the ROC for the PHQ-15 versus the MINI
as golden standard.
Table 3 shows the outcomes of the ROC analysis in
terms of AUC, standard error (SE) and conﬁdence interval
(CI).
The AUC of the PHQ-15 versus the MINI was 0.63
(SE = 0.07; 95% CI: 0.50–0.76).
Discussion
Prevalence
In this study, in a sicklisted population, 23 out of 107
sicklisted employees were classiﬁed with a somatoform
disorder according to the MINI interview, which is a
prevalence of 21.5%. This prevalence is higher than the
prevalence found by Hoedeman et al. [3], in a comparable
sick listed population, performed by questionnaire alone.
The explanation may be that Hoedeman et al. chose a cut
point of 15 or more on the PHQ-15; in view of the present
ﬁndings, using such a high cut point results in missing a
substantial number of cases of somatoform disorders in the
OH setting. Given the ﬁndings from the MINI and given
comparable PHQ-15 mean scores (9.8, SD 5.4) in Hoed-
eman et al.’s study and ours (10.1, SD 5.5), a cut point of
15 may be unnecessarily high to detect somatoform dis-
orders by means of the PHQ-15 in the OH setting.
In the primary care population, Ravestijn et al. found a
mean on the PHQ-15 of 6.1 (SD 5.3). The difference
between primary care patients and sick-listed patients may
play a role in the lower mean scores in the Ravestijn et al.
study; not all primary care patients with MUS will have
such a degree of job disfunction that they are sicklisted. So
the sample in this study in the OH setting probably suffers
more serious disfunctioning than the primary care sample
of Ravesteijn et al. [9].
The MINI classiﬁcations show that the most prevalent
somatoform disorders in this sicklisted population are pain
disorder (48%) and chronic fatigue (22%). This ﬁnding
conﬁrms ﬁndings of Nimnuan et al. [12] who established
that pain and fatigue were MUS that could be found in
many somatoform disorders. Furthermore, in this study,
Irritable Bowel Syndrome (IBS) occurred but less fre-
quently. This conﬁrms ﬁndings of Fink et al. [13] who also
found IBS to be one of the three most frequent MUS in a
primary care population. Apparently, these are the most
relevant symptoms in MUS in the sicklisted population as
well, although prevalence rates for IBS are lower here than
in Fink’s study. The explanation may be that although pain
and fatigue are strongly associated with disfunctioning at
work and thus with being on sick leave, IBS may not be so
disabling in employees in general that it leads to sick leave.
Validity of the PHQ-15
The results presented in this article show that the PHQ-15
can be a highly sensitive screener if a cut point of 6 is used,
Fig. 2 ROC curve for PHQ-15 versus M.I.N.I. ROC-curve with the
dotted line is the reference line
Table 3 Outcomes of the ROC analysis for PHQ-15
AUC Std. error
(a.)
Asymptotic
sig. (b.)
Asymptotic 95%CI
Upper
bound
Lower
bound
PHQ-15 0.63 0.07 0.06 0.50 0.76
AUC area under the curve
CI conﬁdence interval
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and efﬁciency (74.8%) were found at cut point 11, which is
moderate for both measures. However, at a cut point of 11
sensitivity is unacceptably low. If the optimal balance
between sensitivity and speciﬁcity is sought, a cut point of
9 yields sensitivity of 56.5% and speciﬁcity of 61.9%, and
an AUC of 0.63. The validity of the PHQ-15 as a screening
instrument for assessing somatoform disorders in the OH
setting can thus be considered low [14] to moderate [15].
As far as we know, there is no screener for somatoform
disorders with more than moderate validity. Our data show
that sick-listed employees without somatoform disorders
have scores on the PHQ-15 of at least 5, which Kroenke
et al. consider a mild severity of somatic symptoms [11];
however, in this study the mean score on the PHQ-15 is
signiﬁcantly smaller than in the group classiﬁed by the
MINI as having a somatoform disorder. MUS is associated
with poor prognosis, possibly partly due to low recognition
by OHPs and lack of better screeners for somatoform
disorders. Moreover, the number of MUS is associated with
poor prognosis, high medical consumption, and longer
sickness absence [3]. Van der Feltz-Cornelis et al. [16]
reported that adequate recognition and treatment can speed
up Return To Work (RTW) considerably. Therefore, the
use of the PHQ-15 as a screener to detect somatoform
disorders may still be of high clinical relevance.
The cut point of 9 is higher than reported in the primary
care study of Ravestijn et al. which studied the validity of
the PHQ-15 using the SCID-1 as golden standard instead of
the MINI. The study sample of Ravestijn et al. existed of a
high risk primary care population with patients known to
suffer from MUS, frequent attenders and patients with
mental health problems. They reported a sensitivity of 78%
and speciﬁcity of 71% at the optimal cut point of 6 [9]. The
difference between primary care patients and sick-listed
patients may play a role in the lower cut point in the
Ravestijn et al. study. Probably, the PHQ-15 can be used
with a lower cut point in patients in primary care, whereas
in the OH setting, in a sample of sicklisted employees with
a longer duration of sickness absence and thereby a nega-
tive selection of employees with symptoms (most sick-
listed employees return to work with a shorter duration of
sickness absence than 2 weeks), as shown by our data, the
optimal cut point is 9.
Nonresponse Analysis
Our ﬁndings show no relationship between demographic
variables and scores on the PHQ-15 between responders
and non-responders. It can therefore be stated that it does
not matter, for instance, which gender the participant has.
Participants’ scores on either the MINI or PHQ-15 will not
be inﬂuenced by such factors. These results show that there
is no evidence for selectivity within our study sample in
terms of demographic characteristics and severity of
physical symptoms.
Implications for Clinical Practice
The ﬁndings suggest that the PHQ-15 may be used as a
screener in the OH setting, in order to alert the OHP of the
possibility of somatoform disorders. Due to the rather low
efﬁciency of the instrument, it may be best to apply the
screener in high risk groups. The general literature suggests
that patients in the primary care setting with more than 4–6
symptoms were more often disabled [17]. Frequent doctor
visits were also associated with disability. Furthermore,
research in the OH setting showed that such high risk
groups, amongst disabled and sick-listed employees, might
be those with many MUS [18], with high medical con-
sumption [17, 18], who report to be severely disabled [19].
Also, for sick-listed employees with depression or anxiety
disorder it was shown [21] that higher age [20] as well as
negative expectation of the employee regarding duration of
sickness absence contributed to longer duration of sickness
absence. Maybe high age and such expectations of the
employee regarding Return To Work(RTW) should also be
an indication to screen for MUS with the PHQ15. Although
the PHQ-15 might not be helpful enough as a stand-alone
screener, it could have promising possibilities when used in
such high risk groups. The Multidisciplinary guideline for
MUS and somatoform disorder [22] or the Dutch multi-
disciplinairy guideline [7] might be useful to provide the
OHP with evidence based treatment options.
Occupational rehabilitation for employees with somato-
form disorders could be improved by applying manage-
ment rules for management and communication. Evidence
[23] is indirect as effectivity was shown in primary care,
after establishing the diagnosis by psychiatric screening;
and further investigation of the effectivity in the sick-listed
population is needed, but these interventions showed in
primary care improvement of functioning and reduction of
medical consumption. If the process of RTW in employees
with somatoform disorders is hampered, referral for cog-
nitive behavioral therapy (CBT) or multidisciplinary
treatment with graded activity and CBT is indicated. These
treatments have shown to be effective for the outcome of
functioning [24].
Implications for Research
Further research is needed to validate the PHQ-15 in high-
risk groups for somatoform disorder in sicklisted employ-
ees. Furthermore, the low to moderate efﬁciency of the
PHQ-15 may have to do with the possibility of comorbid
depressive and anxiety disorder in somatoform disorders.
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tive inﬂuence on the course of illness as well as on treat-
ment outcome [26, 27]. In this study, no comorbid
conditions were found in the MINI interview. However,
more research is needed to explore this possibility, and its
implications for the validity of the PHQ-15 for this patient
group.
Strengths and Limitations of the Study
A return rate for a mail questionnaire of 22.1% is com-
monly found but it is a small percentage. Another limita-
tion is that not all participants who ﬁlled out the
questionnaire also consented to the MINI interview; 62%
did (N = 107). Nonresponse was probably due to the eli-
gible persons being approached twice, once for the mail
questionnaire, and a second time for the MINI interview.
However, a non-response analysis did not show signiﬁcant
differences between responders and non-responders at least
in terms of demographic characteristics. The reported
health reasons for being sick-listed in this study are
unknown. In a comparable population with a random
sample of Dutch employees being sick-listed between
3 weeks and 2 years [3] the OHP diagnoses were for 40%
mental, 30% musculoskeletal and for 30% other disorders.
The application of the MINI interview to diagnose
somatoform disorders as golden standard is a strength of
this study. For example, in another validation study that
reported high internal reliability, convergent validity and
discriminant validity for the PHQ-15, the PHQ-15 was
compared with the outcomes on the 20-item Short-Form
General Health Survey (SF-20) as golden standard [11].
We compared the PHQ-15 to the more valid MINI.
Another strength of the study is that sicklisted employees
were approached by questionnaire, thus eliminating selec-
tion bias by the OHP. Finally, our study is the ﬁrst to
validate the PHQ-15 in the OH Setting.
Conclusion
This article contributes to the question whether or not the
PHQ-15 can be used as a screening instrument to detect
somatoform disorders in the OH setting. The PHQ-15 is a
questionnaire with moderate validity, i.e. reasonable sen-
sitivity but limited efﬁciency. Due to its sensitivity, it can
be used as a screener for somatoform disorders in the OH
setting. This may be particularly promising in high-risk
groups. In view of the high prevalence of MUS and
somatoform disorders in the OH setting, and in view of the
ﬁndings that no known screener for MUS has been estab-
lished for more than moderate validity [9], the PHQ-15 and
the establishment of its cut point for a sicklisted population
is therefore of signiﬁcant clinical relevance. However,
further research is needed.
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